Zobrazeno 1 - 4
of 4
pro vyhledávání: '"van de Velde, Elien"'
Autor:
Bevers, Sanne, Kooijmans, Sander A.A., Van de Velde, Elien, Evers, Martijn J.W., Seghers, Sofie, Gitz-Francois, Jerney J.J.M., van Kronenburg, Nicky C.H., Fens, Marcel H.A.M., Mastrobattista, Enrico, Hassler, Lucie, Sork, Helena, Lehto, Taavi, Ahmed, Kariem E., El Andaloussi, Samir, Fiedler, Katja, Breckpot, Karine, Maes, Michael, Van Hoorick, Diane, Bastogne, Thierry, Schiffelers, Raymond M., De Koker, Stefaan, Afd Pharmaceutics, Pharmaceutics
Publikováno v:
Molecular Therapy, 30(9), 3078. Cell Press
mRNA vaccines have recently proved to be highly effective against SARS-CoV-2. Key to their success is the lipid-based nanoparticle (LNP), which enables efficient mRNA expression and endows the vaccine with adjuvant properties that drive potent antibo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::028f78bd6d34ae3b03f156b3502fce17
https://doi.org/10.1016/j.ymthe.2022.07.007
https://doi.org/10.1016/j.ymthe.2022.07.007
Autor:
Kooijmans, Sander, Bevers, Sanne, Van De Velde, Elien, Evers, Martijn, Seghers, Sofie, Gitz-François, Jerney, Hassler, Lucie, Breckpot, Karine, Bastogne, Thierry, Schiffelers, Raymond, De Koker, Stefaan
Publikováno v:
Annual Meeting of the Controlled Release Society, CRS 2021
Annual Meeting of the Controlled Release Society, CRS 2021, Jul 2021, Virtual, United States
Annual Meeting of the Controlled Release Society, CRS 2021, Jul 2021, Virtual, United States
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8d0ff0c73a667be4883a5ea4f646ec84
https://hal.univ-lorraine.fr/hal-03298753
https://hal.univ-lorraine.fr/hal-03298753
Autor:
Bevers, Sanne, Kooijmans, Sander, van de Velde, Elien, Evers, Martijn, Seghers, Sofie, Gitz-François, Jerney, Hassler, Lucie, Breckpot, Karine, Bastogne, Thierry, Schiffelers, Raymond, De Koker, Stefaan
Publikováno v:
18th CIMT Annual Meeting, CIMT 2021
18th CIMT Annual Meeting, CIMT 2021, CIMT Association for Cancer Immunotherapy, May 2021, Mainz, Germany
18th CIMT Annual Meeting
18th CIMT Annual Meeting, CIMT Association for Cancer Immunotherapy, May 2021, Mainz, Germany
18th CIMT Annual Meeting, CIMT 2021, CIMT Association for Cancer Immunotherapy, May 2021, Mainz, Germany
18th CIMT Annual Meeting
18th CIMT Annual Meeting, CIMT Association for Cancer Immunotherapy, May 2021, Mainz, Germany
International audience; Intravenous (i‧v.) delivery of vaccines is emerging as an appealing approach to evoke high-quality T-cell responses needed to combat tumors. Messenger RNA (mRNA) holds huge potential to use in vaccination because of its ease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::112c625deca91ada3a9146815ad64022
https://hal.univ-lorraine.fr/hal-03297832
https://hal.univ-lorraine.fr/hal-03297832
Autor:
Bevers S; eTheRNA Immunotherapies, 2845 Niel, Belgium; Laboratory for Molecular and Cellular Therapy (LMCT), Free University of Brussels, 1090 Jette, Belgium., Kooijmans SAA; CDL Research, University Medical Center Utrecht, 3508 GA Utrecht, the Netherlands., Van de Velde E; eTheRNA Immunotherapies, 2845 Niel, Belgium., Evers MJW; CDL Research, University Medical Center Utrecht, 3508 GA Utrecht, the Netherlands., Seghers S; eTheRNA Immunotherapies, 2845 Niel, Belgium., Gitz-Francois JJJM; CDL Research, University Medical Center Utrecht, 3508 GA Utrecht, the Netherlands., van Kronenburg NCH; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, the Netherlands., Fens MHAM; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, the Netherlands., Mastrobattista E; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, the Netherlands., Hassler L; CYBERnano, 54000 Nancy, France., Sork H; Institute of Technology, University of Tartu, 50411 Tartu, Estonia., Lehto T; Institute of Technology, University of Tartu, 50411 Tartu, Estonia; Department of Laboratory Medicine, Karolinksa Institutet, 141 52 Huddinge, Sweden., Ahmed KE; Department of Laboratory Medicine, Karolinksa Institutet, 141 52 Huddinge, Sweden., El Andaloussi S; Department of Laboratory Medicine, Karolinksa Institutet, 141 52 Huddinge, Sweden., Fiedler K; eTheRNA Immunotherapies, 2845 Niel, Belgium., Breckpot K; Laboratory for Molecular and Cellular Therapy (LMCT), Free University of Brussels, 1090 Jette, Belgium., Maes M; eTheRNA Immunotherapies, 2845 Niel, Belgium., Van Hoorick D; eTheRNA Immunotherapies, 2845 Niel, Belgium., Bastogne T; CYBERnano, 54000 Nancy, France; CRAN, Université de Lorraine, CNRS, INRIA BIGS, 54506 Vandœuvre-lès-Nancy, France., Schiffelers RM; CDL Research, University Medical Center Utrecht, 3508 GA Utrecht, the Netherlands., De Koker S; eTheRNA Immunotherapies, 2845 Niel, Belgium. Electronic address: stefaan.dekoker@etherna.be.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2022 Sep 07; Vol. 30 (9), pp. 3078-3094. Date of Electronic Publication: 2022 Jul 12.